Inglourious ROI

With their “media empire” on the verge of collapse, the Weinstein brothers were pulling out all the stops to promote the opening of Inglourious Basterds last week. They’ve even played the contrition card in explaining to the NYTimes that they lost their focus after leaving Disney and starting their own company, using investor money to buy a fashion line, invest in a TV channel and a social networking site, and other activities that don’t qualify as making movies people would pay to see. (Here’s a fun takedown of that article, at the AV Club.)

So it must be gratifying to them that the new Tarantino movie was #1 at the box office this weekend, with nearly $38 million in tickets sold. The marketing is a bit misleading, since the Basterds — a squad of Jewish-American soldiers who ambush and scalp Nazis in occupied France — don’t actually get much screen time. But that’s a minor quibble. I still enjoyed the heck out of the film; it just wasn’t the movie it was marketed as. (I’m assuming the 4-hour DVD version will have plenty more carnage.)

Which leads me to this WSJ article about the movie’s performance and its marketing. It highlights the problems the Weinstein Co. still faces, but the article also seems to have buried the lede:

Part of the success of “Inglourious Basterds,” which was directed by Quentin Tarantino, comes from its $35 million marketing campaign, which Weinstein Co. executives say Harvey Weinstein approached with a renewed focus after missing the mark of previous campaigns. Last year for example, the company used stick figure drawings to sell Kevin Smith’s “Zack and Miri Make a Porno,” which underperformed at the box office.

Let me see if I have this correct: the film grossed $38 million domestically and the marketing cost $35 million? With another $27 million in overseas sales, the movie made $65 million last weekend.

If that $35 mil. covers worldwide marketing, then they spent 54 cents for every dollar in ticket sales. If it was only for the domestic campaign, then it was almost 1 dollar spent for 1 dollar in sales (which are shared with the movie theaters).

Between this marketing campaign and the movie’s production cost of $65-70 million, that means this big success is still $35-40 million behind the 8-ball. Sure, there a lot of other revenue streams to help them close the gap, but this is probably not a good model for running a business.

Left-Wing Nutjobbery

Another day, another pinko leftist newspaper railing about income inequality and how it demolishes the Social Security fund:

Executives and other highly compensated employees now receive more than one-third of all pay in the U.S., according to a Wall Street Journal analysis of Social Security Administration data — without counting billions of dollars more in pay that remains off federal radar screens that measure wages and salaries.

. . . The growing portion of pay that exceeds the maximum amount subject to payroll taxes has contributed to the weakening of the Social Security trust fund. In May, the government said the Social Security fund would be exhausted in 2037, four years earlier than was predicted in 2008.

I was going to go into a whole Colbertian ramble on the left-wing moonbats at the Wall Street Journal, but frankly it’s just a good article about the ramifications of executive pay scales. Give it a read.

What It Is: 7/13/09

What I’m reading: Killshot, by Elmore Leonard, and Asterios Polyp, by David Mazzucchelli.

What I’m listening to: LP by Discovery, which was okay, but a little too deliberately like a poor man’s Postal Service.

What I’m watching: Just The Tall Guy (one of my favorite movies back in college, but one I haven’t watched in at least a decade), and this week’s Deadliest Catch. Amy had a pretty late work-week, and I tend not to watch a lot of stuff by myself.

What I’m drinking: Plymouth & Q Tonic.

What Rufus is up to: Making his first foray into a lake.

Where I’m going: Back to the office! Eek!

What I’m happy about: That I managed to reduce my daily caffeine intake by more than 50% during this vacation! (Also, that I managed to clear around 225 square feet of my backyard by pulling up rampant forsythia, cleaned out my garage, took care of a ton of other items on my to-do list, and still got to spend time with my brother & his family.)

What I’m sad about: That the downstairs freezer and the washing machine both crapped out last week. We got a new washer on Sunday and have a repair guy coming next week for the freezer.

What I’m worried about: Getting back into the rhythm of working at my office, as opposed to working at home.

What I’m pondering: How much of my Top Companies issue will be out of date by the time it sees print.

Last day!

The production schedule read, “Final Materials to Printer – July 2,” and I’m gonna get those final materials to the printer by July 2! Just a couple hundred words more about Pfizer and a brief writeup about Abbott Laboratories, and this year’s Top 20 Pharma / Top 10 Biopharma ish will be finished!

So don’t expect any more posts today.

In other news, it looks like the constant dreariness and rainfall of June has had at least one positive effect: the deer have had enough to eat in the woods and have (mostly) left my tigerlilies alone!